Judith A. Besserer

459 total citations
10 papers, 397 citations indexed

About

Judith A. Besserer is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Judith A. Besserer has authored 10 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Organic Chemistry and 2 papers in Infectious Diseases. Recurrent topics in Judith A. Besserer's work include Cancer therapeutics and mechanisms (4 papers), Biochemical and Molecular Research (4 papers) and DNA and Nucleic Acid Chemistry (3 papers). Judith A. Besserer is often cited by papers focused on Cancer therapeutics and mechanisms (4 papers), Biochemical and Molecular Research (4 papers) and DNA and Nucleic Acid Chemistry (3 papers). Judith A. Besserer collaborates with scholars based in United States. Judith A. Besserer's co-authors include David W. Fry, Theodore J. Boritzki, Robert Jackson, Wilbur R. Leopold, Bernard J. Sloan, Edward F. Elslager, Randall W. Steinkampf, David A. Berry, P.D. Cook and Wayne D. Klohs and has published in prestigious journals such as Biochemical Pharmacology, Molecular Pharmacology and Cancer Letters.

In The Last Decade

Judith A. Besserer

10 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Judith A. Besserer United States 8 241 122 95 59 52 10 397
Glenys M. Otter United States 11 211 0.9× 99 0.8× 111 1.2× 46 0.8× 32 0.6× 24 369
Ming-Yu Chu United States 5 248 1.0× 89 0.7× 61 0.6× 69 1.2× 20 0.4× 7 352
Richard W. Dyke United States 10 192 0.8× 157 1.3× 48 0.5× 30 0.5× 41 0.8× 13 415
Dorothy H. Trites United States 11 219 0.9× 140 1.1× 73 0.8× 28 0.5× 14 0.3× 15 378
Robert L. Dion United States 9 378 1.6× 67 0.5× 95 1.0× 41 0.7× 16 0.3× 15 578
Randall W. Steinkampf United States 9 225 0.9× 159 1.3× 82 0.9× 18 0.3× 10 0.2× 13 385
Chiara Rusconi Italy 15 123 0.5× 182 1.5× 78 0.8× 53 0.9× 14 0.3× 53 563
Gary A. Cain United States 11 261 1.1× 50 0.4× 192 2.0× 11 0.2× 63 1.2× 19 555
Katsuji Kuwakado Japan 10 251 1.0× 91 0.7× 29 0.3× 36 0.6× 8 0.2× 16 456
Krishna Vaddi United States 13 212 0.9× 188 1.5× 137 1.4× 14 0.2× 36 0.7× 20 656

Countries citing papers authored by Judith A. Besserer

Since Specialization
Citations

This map shows the geographic impact of Judith A. Besserer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith A. Besserer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith A. Besserer more than expected).

Fields of papers citing papers by Judith A. Besserer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith A. Besserer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith A. Besserer. The network helps show where Judith A. Besserer may publish in the future.

Co-authorship network of co-authors of Judith A. Besserer

This figure shows the co-authorship network connecting the top 25 collaborators of Judith A. Besserer. A scholar is included among the top collaborators of Judith A. Besserer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith A. Besserer. Judith A. Besserer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Boritzki, Theodore J., et al.. (1988). Inhibition of type II topoisomerase by fostriecin. Biochemical Pharmacology. 37(21). 4063–4068. 101 indexed citations
2.
Fry, David W. & Judith A. Besserer. (1988). Characterization of trimetrexate transport in human lymphoblastoid cells and development of impaired influx as a mechanism of resistance to lipophilic antifolates.. PubMed. 48(24 Pt 1). 6986–91. 48 indexed citations
3.
4.
Jackson, Robert, Theodore J. Boritzki, Judith A. Besserer, et al.. (1987). Biochemical pharmacology and experimental chemotherapy studies with guanine-7-oxide, a novel purine antibiotic. Advances in Enzyme Regulation. 26. 301–316. 7 indexed citations
5.
Klohs, Wayne D., Randall W. Steinkampf, Judith A. Besserer, & David W. Fry. (1986). Cross resistance of pleiotropically drug resistant P338 leukemia cells to the lipophilic antifolates trimetrexate and BW 301U. Cancer Letters. 31(3). 253–260. 25 indexed citations
6.
Leopold, Wilbur R., et al.. (1985). Dezaguanine mesylate: a new antipurine antimetabolite. Investigational New Drugs. 3(3). 223–231. 7 indexed citations
7.
Fry, David W., Theodore J. Boritzki, Judith A. Besserer, & Robert Jackson. (1985). In vitro DNA strand scission and inhibition of nucleic acid synthesis in L1210 leukemia cells by a new class of DNA complexers, the anthra[1,9-cd]pyrazol-6(2H)-ones (anthrapyrazoles). Biochemical Pharmacology. 34(19). 3499–3508. 46 indexed citations
8.
Boritzki, Theodore J., David A. Berry, Judith A. Besserer, et al.. (1985). Biochemical and antitumor activity of tiazofurin and its selenium analog (2-β-D-ribofuranosyl-4-selenazolecarboxamide). Biochemical Pharmacology. 34(7). 1109–1114. 42 indexed citations
9.
Jackson, Robert, David W. Fry, Theodore J. Boritzki, et al.. (1984). Biochemical pharmacology of the lipophilic antifolate, trimetrexate. Advances in Enzyme Regulation. 22. 187–206. 78 indexed citations
10.
Fry, David W., Judith A. Besserer, & Theodore J. Boritzki. (1984). Transport of the antitumor antibiotic Cl-920 into L1210 leukemia cells by the reduced folate carrier system.. PubMed. 44(8). 3366–70. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Glenys M. Otter Breakdown of academic impact, for papers by Ming-Yu Chu Breakdown of academic impact, for papers by Richard W. Dyke Breakdown of academic impact, for papers by Dorothy H. Trites Breakdown of academic impact, for papers by Robert L. Dion Breakdown of academic impact, for papers by Randall W. Steinkampf Breakdown of academic impact, for papers by Chiara Rusconi Breakdown of academic impact, for papers by Gary A. Cain Breakdown of academic impact, for papers by Katsuji Kuwakado Breakdown of academic impact, for papers by Krishna Vaddi
Rankless by CCL
2026